Notice of interruption or termination of supply of a human drug
 DateHolder ▼CodeDrugDate fromSubject
 8.3.20213M Deutschland GmbH (MDU)80441Ubistesin forte (sol inj 50x1,7 ml (karpula skl.))12.4.2021R
 8.3.20213M Deutschland GmbH (MDU)76538MEPIVASTESIN (sol inj 50x1,7 ml (karpila))7.5.2021R
 8.3.20213M Deutschland GmbH (MDU)80440Ubistesin (sol inj 50x1,7 ml (karpula skl.))7.5.2021R
 17.1.2020A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)84098Spasmomen (tbl flm 30x40 mg (blis.Al/PVC/PVDC))30.4.2020Z
 26.9.2019AbbVie Deutschland GmbH & Co. KG (ABV-DE)40793Humira 40 mg/0,8 ml injekčný roztok (sol inj 2x0,8 ml/40 mg (liek.inj.skl.))1.10.2019Z
 14.8.2020AbbVie s.r.o. (ABV)34992CHIROCAINE 5 mg/ml (sol ijf 10x10 ml (amp.PP))14.8.2020Z
 20.12.2019AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))12.12.2019R
 10.1.2020AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))10.1.2020O
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)5715ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x1 ml (liek.inj.skl.))14.11.2019O
 30.7.2019Accord Healthcare Polska Sp. z o.o. (AOK)4516CClozapine Accord 100 mg tablety (tablety 50x100 mg (blis.Al/PVC/PVDC))17.7.2019O
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05194Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x100 ml/5 g (liek.inj.skl.))19.11.2019R
 10.7.2019Accord Healthcare Polska Sp. z o.o. (AOK)2494AGemcitabine Accord 100 mg/ml infúzny koncentrát (con inf 1x200 mg/2 ml (liek.inj.skl.))19.6.2019R
 26.9.2019Accord Healthcare Polska Sp. z o.o. (AOK)5723ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x10 ml (liek.inj.skl.))1.10.2019R
 9.10.2019Accord Healthcare Polska Sp. z o.o. (AOK)76907Midazolam Accord 5 mg/ml (sol ijf 10x1 ml/5 mg (amp.skl.))11.10.2019R
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05193Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x20 ml/1 g (liek.inj.skl.))22.11.2019R

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To